BNP Paribas Financial Markets’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4M Buy
426,667
+86,210
+25% +$809K ﹤0.01% 1485
2025
Q1
$2.42M Sell
340,457
-98,001
-22% -$697K ﹤0.01% 1584
2024
Q4
$5.11M Buy
438,458
+192,096
+78% +$2.24M ﹤0.01% 1213
2024
Q3
$5.06M Buy
246,362
+115,351
+88% +$2.37M ﹤0.01% 1010
2024
Q2
$2.93M Buy
131,011
+56,496
+76% +$1.26M ﹤0.01% 1171
2024
Q1
$2.05M Sell
74,515
-135,646
-65% -$3.73M ﹤0.01% 1506
2023
Q4
$6.41M Buy
210,161
+1,930
+0.9% +$58.8K 0.01% 867
2023
Q3
$6.58M Buy
208,231
+13,023
+7% +$412K 0.01% 754
2023
Q2
$7.96M Buy
195,208
+497
+0.3% +$20.3K 0.01% 724
2023
Q1
$7.26M Buy
194,711
+113,839
+141% +$4.24M 0.01% 765
2022
Q4
$2.82M Sell
80,872
-33,459
-29% -$1.17M ﹤0.01% 1102
2022
Q3
$6.4M Buy
114,331
+64,651
+130% +$3.62M 0.01% 873
2022
Q2
$2.57M Sell
49,680
-10,261
-17% -$531K ﹤0.01% 1148
2022
Q1
$4.36M Buy
59,941
+22,983
+62% +$1.67M 0.01% 1007
2021
Q4
$4.37M Buy
36,958
+23,187
+168% +$2.74M 0.01% 1026
2021
Q3
$1.85M Buy
13,771
+11,341
+467% +$1.52M ﹤0.01% 1482
2021
Q2
$393K Sell
2,430
-6,034
-71% -$977K ﹤0.01% 2074
2021
Q1
$679K Buy
8,464
+1,678
+25% +$135K ﹤0.01% 1880
2020
Q4
$369K Sell
6,786
-4,993
-42% -$272K ﹤0.01% 1984
2020
Q3
$234K Buy
11,779
+5,566
+90% +$111K ﹤0.01% 2090
2020
Q2
$131K Sell
6,213
-14,663
-70% -$308K ﹤0.01% 2054
2020
Q1
$255K Buy
20,876
+15,532
+291% +$190K ﹤0.01% 2157
2019
Q4
$78.4K Sell
5,344
-892
-14% -$13.1K ﹤0.01% 2748
2019
Q3
$83.3K Buy
6,236
+1,726
+38% +$23K ﹤0.01% 2585
2019
Q2
$73.8K Sell
4,510
-3,138
-41% -$51.4K ﹤0.01% 2594
2019
Q1
$131K Buy
7,648
+6,914
+942% +$118K ﹤0.01% 2383
2018
Q4
$10K Sell
734
-3,759
-84% -$51.3K ﹤0.01% 2678
2018
Q3
$129K Sell
4,493
-3,317
-42% -$94.9K ﹤0.01% 1970
2018
Q2
$214K Buy
7,810
+4,479
+134% +$123K ﹤0.01% 1799
2018
Q1
$70.3K Sell
3,331
-555
-14% -$11.7K ﹤0.01% 2797
2017
Q4
$74.7K Buy
3,886
+2,414
+164% +$46.4K ﹤0.01% 2801
2017
Q3
$36.6K Sell
1,472
-23
-2% -$572 ﹤0.01% 2828
2017
Q2
$23.9K Buy
1,495
+1,300
+667% +$20.8K ﹤0.01% 3038
2017
Q1
$2.75K Sell
195
-313
-62% -$4.41K ﹤0.01% 2888
2016
Q4
$6.66K Sell
508
-50
-9% -$656 ﹤0.01% 3042
2016
Q3
$9.5K Buy
558
+282
+102% +$4.8K ﹤0.01% 3185
2016
Q2
$5.89K Buy
+276
New +$5.89K ﹤0.01% 3191